US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Charles River Laboratories

273.00

-5.3500-1.92%

Post-market: 273.000.00000.00%17:36 EDT

Volume:764.67K

Turnover:208.79M

Market Cap:13.03B

PE:-55.93

High:275.88

Open:275.38

Low:272.06

Close:278.35

52wk High:303.31

52wk Low:144.26

Shares:47.74M

Float Shares:47.20M

Volume Ratio:1.09

T/O Rate:1.62%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-4.8814

EPS(LYR):-2.9122

ROE:-7.52%

ROA:4.11%

PB:4.59

PE(LYR):-93.75

Loading ...

Overview Company News Filings

Leerink sees favorable readthrough to Crinetics after Camurus’ Oclaiz CRL

Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE)

Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors

Analysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)

RBC Capital Keeps Their Buy Rating on Charles River Labs (CRL)

Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says

MT Newswires Live

Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)

Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS

Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day

Max Smock Reiterates Buy on Charles River Laboratories, Citing Achievable 2026 Targets and Margin Expansion Upside

Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors

URA announces nine new sites under Confirmed List in 2H2026 GLS programme, including white site at Jurong Lake District

Charles River Laboratories posts investor presentation on growth strategy, demand trends and 2026 outlook

FDA Declines Approval for Cingulate's ADHD Treatment Candidate

Nyse Order Imbalance 67834.0 Shares on Buy Side

THOMSON REUTERS

Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients

Charles River Labs to present at William Blair Growth Stock Conference

Charles River Laboratories International Inc. Stock Advances 10.2%, Outperforms Peers

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnest.com/stock/CRL/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"CRL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRL\",,,,,undefined,":{"symbol":"CRL","market":"US","secType":"STK","nameCN":"Charles River Laboratories","latestPrice":273,"timestamp":1789070400000,"preClose":278.35,"halted":0,"volume":764667,"hourTrading":{"tag":"盘后","latestPrice":273,"preClose":273,"latestTime":"17:36 EDT","volume":26135,"amount":7134855,"timestamp":1789076193743,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.019220405963714826,"floatShares":47195822,"shares":47738872,"eps":-4.881382,"marketStatus":"Post-Mkt","change":-5.35,"latestTime":"09-10 17:50:42 EDT","open":275.38,"high":275.88,"low":272.0599,"amount":208788118.68150002,"amplitude":0.013724,"askPrice":277.69,"askSize":60,"bidPrice":272.18,"bidSize":6,"shortable":3,"etf":0,"ttmEps":-4.881382,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789084800000},"marketStatusCode":4,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":278.35,"preHourTrading":{"tag":"盘前","latestPrice":278.35,"preClose":278.35,"latestTime":"04:00 EDT","volume":26,"amount":7237.1,"timestamp":1789027206864,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":273,"preClose":273,"latestTime":"17:36 EDT","volume":26135,"amount":7134855,"timestamp":1789076193743,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.089247,"impliedVol":0.4979,"impliedVolPercentile":0.5777},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRL\",,,,,undefined,":{"symbol":"CRL","floatShares":47195822,"roa":"4.11%","roe":"-7.52%","lyrEps":-2.912153,"volumeRatio":1.089247,"shares":47738872,"dividePrice":0,"high":275.88,"amplitude":0.013724,"preClose":278.35,"low":272.0599,"week52Low":144.26,"pbRate":"4.59","psRate":"3.26","week52High":303.305,"institutionHeld":0.86,"latestPrice":273,"committee":-0.818182,"eps":-4.881382,"divideRate":0,"volume":764667,"delay":0,"ttmEps":-4.881382,"open":275.38,"prevYearClose":199.48,"prevWeekClose":288.5,"prevMonthClose":288.24,"prevQuarterClose":226.79,"fiveDayClose":291.76,"twentyDayClose":284.37,"sixtyDayClose":188.47},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"CRL","fiscalQuarterEnding":"2026/06","expectedEps":2.72,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"pre","actualEps":3.02},{"market":"US","date":"2026-05-07","symbol":"CRL","fiscalQuarterEnding":"2026/03","expectedEps":1.96,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778126400000,"reportTimeType":"pre","actualEps":2.06},{"date":"2026-02-18","symbol":"CRL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":2.33,"defaultRemindTime":1771405200000,"name":null,"time":"Pre-MKt","dateTimestamp":1771390800000,"actualEps":null},{"market":"US","date":"2025-11-05","symbol":"CRL","fiscalQuarterEnding":"2025/09","expectedEps":2.32,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1762318800000,"reportTimeType":"pre","actualEps":2.43},{"market":"US","date":"2025-08-06","symbol":"CRL","fiscalQuarterEnding":"2025/06","expectedEps":2.5,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"pre","actualEps":3.12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2632,"buy":0.4737,"hold":0.2632,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4737,"analysts":19,"updateTime":1785988800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRL","date":"2026-09-09","current":-55.926785,"percent":0.227384,"low":-447.231077,"twenty":-58.65089,"median":22.89213,"eighty":29.109011,"high":407.557355,"avg":-4.808321,"sd":120.940818,"marketCap":13403165702},"quantilePoints":[{"date":"2021-09-10","current":56.112458,"twenty":28.771964,"median":35.357488,"eighty":43.302055,"marketCap":22224910302},{"date":"2021-09-17","current":56.042477,"twenty":28.795646,"median":35.488743,"eighty":43.419945,"marketCap":22197192159},{"date":"2021-09-24","current":58.313695,"twenty":28.822922,"median":35.615121,"eighty":43.573795,"marketCap":23096771862},{"date":"2021-10-01","current":53.019275,"twenty":28.853262,"median":35.82889,"eighty":43.83049,"marketCap":20999768421},{"date":"2021-10-08","current":52.061164,"twenty":28.875115,"median":35.934891,"eighty":43.960435,"marketCap":20620281857},{"date":"2021-10-15","current":51.34608,"twenty":28.915864,"median":36.045137,"eighty":44.05704,"marketCap":20337052841},{"date":"2021-10-22","current":53.518052,"twenty":28.950184,"median":36.159246,"eighty":44.149213,"marketCap":21197323179},{"date":"2021-10-29","current":57.089655,"twenty":28.977663,"median":36.25009,"eighty":44.261141,"marketCap":22611956358},{"date":"2021-11-05","current":47.745827,"twenty":28.995518,"median":36.34623,"eighty":44.347057,"marketCap":18935756436},{"date":"2021-11-12","current":49.104795,"twenty":29.067805,"median":36.513032,"eighty":44.446527,"marketCap":19474716218},{"date":"2021-11-19","current":48.337513,"twenty":29.093675,"median":36.637748,"eighty":44.550609,"marketCap":19170415892},{"date":"2021-11-26","current":47.75219,"twenty":29.11771,"median":36.720489,"eighty":44.623267,"marketCap":18938279656},{"date":"2021-12-03","current":45.474519,"twenty":29.158298,"median":36.935582,"eighty":44.740137,"marketCap":18034966914},{"date":"2021-12-10","current":45.520327,"twenty":29.19077,"median":37.023651,"eighty":44.777968,"marketCap":18053134098},{"date":"2021-12-17","current":46.183269,"twenty":29.230369,"median":37.413057,"eighty":44.89527,"marketCap":18316053617},{"date":"2021-12-23","current":46.978545,"twenty":29.259362,"median":37.574141,"eighty":44.968368,"marketCap":18631456110},{"date":"2021-12-31","current":47.943056,"twenty":29.28272,"median":37.839647,"eighty":45.132965,"marketCap":19013976255},{"date":"2022-01-07","current":41.822612,"twenty":29.313496,"median":37.999335,"eighty":45.141446,"marketCap":16586638663},{"date":"2022-01-14","current":45.17295,"twenty":29.361435,"median":38.282449,"eighty":45.184883,"marketCap":17915366288},{"date":"2022-01-21","current":41.31109,"twenty":29.384996,"median":38.380564,"eighty":45.184883,"marketCap":16383771779},{"date":"2022-01-28","current":40.938265,"twenty":29.405743,"median":38.505509,"eighty":45.184883,"marketCap":16235911090},{"date":"2022-02-04","current":42.709503,"twenty":29.456071,"median":38.577622,"eighty":45.184883,"marketCap":16938375524},{"date":"2022-02-11","current":42.112728,"twenty":29.498941,"median":38.626542,"eighty":45.184883,"marketCap":16701697493},{"date":"2022-02-18","current":37.912764,"twenty":29.540582,"median":38.678961,"eighty":45.184883,"marketCap":14823208259},{"date":"2022-02-25","current":38.242036,"twenty":29.57101,"median":38.678961,"eighty":45.184883,"marketCap":14951947679},{"date":"2022-03-04","current":35.897103,"twenty":29.647546,"median":38.678961,"eighty":45.184883,"marketCap":14035121066},{"date":"2022-03-11","current":33.513432,"twenty":29.712098,"median":38.678961,"eighty":45.184883,"marketCap":13103148638},{"date":"2022-03-18","current":37.02954,"twenty":29.762137,"median":38.678961,"eighty":45.184883,"marketCap":14477883698},{"date":"2022-03-25","current":36.039142,"twenty":29.806939,"median":38.678961,"eighty":45.184883,"marketCap":14090655717},{"date":"2022-04-01","current":37.273589,"twenty":29.885844,"median":38.678961,"eighty":45.184883,"marketCap":14573302327},{"date":"2022-04-08","current":39.047784,"twenty":29.944209,"median":38.701879,"eighty":45.184883,"marketCap":15266980612},{"date":"2022-04-14","current":36.98105,"twenty":29.992225,"median":38.701879,"eighty":45.184883,"marketCap":14458924777},{"date":"2022-04-22","current":35.473899,"twenty":30.043214,"median":38.701879,"eighty":45.184883,"marketCap":13869656157},{"date":"2022-04-29","current":31.378608,"twenty":30.064982,"median":38.701879,"eighty":45.184883,"marketCap":12268471078},{"date":"2022-05-06","current":29.093697,"twenty":30.089092,"median":38.701879,"eighty":45.184883,"marketCap":12291330637},{"date":"2022-05-13","current":28.357471,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":11980294036},{"date":"2022-05-20","current":27.97626,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":11819242630},{"date":"2022-05-27","current":29.391669,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":12417215832},{"date":"2022-06-03","current":29.219703,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":12344564882},{"date":"2022-06-10","current":26.396102,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":11151666770},{"date":"2022-06-17","current":24.547774,"twenty":30.078152,"median":38.701879,"eighty":45.184883,"marketCap":10370796071},{"date":"2022-06-24","current":27.216245,"twenty":30.053019,"median":38.706743,"eighty":45.196815,"marketCap":11498155915},{"date":"2022-07-01","current":26.315531,"twenty":30.004667,"median":38.706743,"eighty":45.196815,"marketCap":11117627513},{"date":"2022-07-08","current":27.829549,"twenty":29.968548,"median":38.706743,"eighty":45.196815,"marketCap":11757260701},{"date":"2022-07-15","current":26.426166,"twenty":29.897558,"median":38.706743,"eighty":45.196815,"marketCap":11164367985},{"date":"2022-07-22","current":28.501777,"twenty":29.845943,"median":38.706743,"eighty":45.196815,"marketCap":12041259868},{"date":"2022-07-29","current":30.128835,"twenty":29.77155,"median":38.706743,"eighty":45.196815,"marketCap":12728649624},{"date":"2022-08-05","current":25.597984,"twenty":29.717081,"median":38.706743,"eighty":45.196815,"marketCap":11348789626},{"date":"2022-08-12","current":26.732242,"twenty":29.645163,"median":38.706743,"eighty":45.196815,"marketCap":11851659164},{"date":"2022-08-19","current":24.963171,"twenty":29.568724,"median":38.706743,"eighty":45.196815,"marketCap":11067346970},{"date":"2022-08-26","current":23.496976,"twenty":29.509527,"median":38.706743,"eighty":45.196815,"marketCap":10417313906},{"date":"2022-09-02","current":22.97268,"twenty":29.478815,"median":38.706743,"eighty":45.196815,"marketCap":10184868593},{"date":"2022-09-09","current":25.037743,"twenty":29.419005,"median":38.706743,"eighty":45.196815,"marketCap":11100408119},{"date":"2022-09-16","current":22.911875,"twenty":29.389532,"median":38.706743,"eighty":45.196815,"marketCap":10157911040},{"date":"2022-09-23","current":21.512221,"twenty":29.36457,"median":38.706743,"eighty":45.196815,"marketCap":9537378695},{"date":"2022-09-30","current":22.578023,"twenty":29.276296,"median":38.706743,"eighty":45.196815,"marketCap":10009898817},{"date":"2022-10-07","current":23.556634,"twenty":29.218215,"median":38.706743,"eighty":45.196815,"marketCap":10443762826},{"date":"2022-10-14","current":22.626208,"twenty":29.168267,"median":38.706743,"eighty":45.196815,"marketCap":10031261406},{"date":"2022-10-21","current":22.965796,"twenty":29.107452,"median":38.693299,"eighty":45.196815,"marketCap":10181816795},{"date":"2022-10-28","current":24.605227,"twenty":29.071326,"median":38.655972,"eighty":45.196815,"marketCap":10908653452},{"date":"2022-11-04","current":25.689178,"twenty":28.969377,"median":38.568755,"eighty":45.196815,"marketCap":11210603063},{"date":"2022-11-11","current":28.713491,"twenty":28.916309,"median":38.522109,"eighty":45.196815,"marketCap":12530395399},{"date":"2022-11-18","current":28.23198,"twenty":28.865918,"median":38.522109,"eighty":45.196815,"marketCap":12320266550},{"date":"2022-11-25","current":28.321753,"twenty":28.797094,"median":38.522109,"eighty":45.196815,"marketCap":12359443115},{"date":"2022-12-02","current":25.959664,"twenty":28.739105,"median":38.522109,"eighty":45.196815,"marketCap":11328641544},{"date":"2022-12-09","current":24.50347,"twenty":28.624068,"median":38.522109,"eighty":45.196815,"marketCap":10693167131},{"date":"2022-12-16","current":25.115561,"twenty":28.536763,"median":38.522109,"eighty":45.196815,"marketCap":10960280075},{"date":"2022-12-23","current":25.474654,"twenty":28.456988,"median":38.522109,"eighty":45.196815,"marketCap":11116986336},{"date":"2022-12-30","current":25.404701,"twenty":28.346448,"median":38.522109,"eighty":45.196815,"marketCap":11086459142},{"date":"2023-01-06","current":25.630883,"twenty":28.346448,"median":38.522109,"eighty":45.196815,"marketCap":11185163735},{"date":"2023-01-13","current":27.120888,"twenty":28.386332,"median":38.522109,"eighty":45.196815,"marketCap":11835392958},{"date":"2023-01-20","current":28.3509,"twenty":28.386332,"median":38.522109,"eighty":45.196815,"marketCap":12372162779},{"date":"2023-01-27","current":28.574751,"twenty":28.463533,"median":38.522109,"eighty":45.196815,"marketCap":12469849799},{"date":"2023-02-03","current":29.188008,"twenty":28.496486,"median":38.522109,"eighty":45.196815,"marketCap":12737471529},{"date":"2023-02-10","current":28.615557,"twenty":28.575533,"median":38.522109,"eighty":45.196815,"marketCap":12487657328},{"date":"2023-02-17","current":29.119221,"twenty":28.587662,"median":38.416506,"eighty":45.196815,"marketCap":12707453122},{"date":"2023-02-24","current":23.049217,"twenty":28.536763,"median":38.282048,"eighty":45.196815,"marketCap":11207128689},{"date":"2023-03-03","current":24.327457,"twenty":28.463533,"median":38.044305,"eighty":45.196815,"marketCap":11828642264},{"date":"2023-03-10","current":21.23829,"twenty":28.384711,"median":37.910628,"eighty":45.196815,"marketCap":10326608638},{"date":"2023-03-17","current":20.229539,"twenty":28.324257,"median":37.727656,"eighty":45.196815,"marketCap":9836127868},{"date":"2023-03-24","current":20.320767,"twenty":28.260928,"median":37.569288,"eighty":45.196815,"marketCap":9880485277},{"date":"2023-03-31","current":21.162791,"twenty":28.208144,"median":37.439516,"eighty":45.184883,"marketCap":10289899059},{"date":"2023-04-06","current":20.525244,"twenty":28.148686,"median":37.311256,"eighty":45.184883,"marketCap":9979907054},{"date":"2023-04-14","current":21.55916,"twenty":28.084844,"median":37.073363,"eighty":45.196815,"marketCap":10482624351},{"date":"2023-04-21","current":20.755935,"twenty":27.982754,"median":36.993435,"eighty":45.196815,"marketCap":10092075214},{"date":"2023-04-28","current":19.263781,"twenty":27.917889,"median":36.931826,"eighty":45.196815,"marketCap":9366551165},{"date":"2023-05-05","current":19.868822,"twenty":27.862884,"median":36.66086,"eighty":45.208748,"marketCap":9660737655},{"date":"2023-05-12","current":20.185622,"twenty":27.783384,"median":36.438142,"eighty":45.208748,"marketCap":10018830498},{"date":"2023-05-19","current":20.548042,"twenty":27.693471,"median":36.234104,"eighty":45.208748,"marketCap":10198712425},{"date":"2023-05-26","current":20.0974,"twenty":27.630652,"median":36.024938,"eighty":45.208748,"marketCap":9975042981},{"date":"2023-06-02","current":20.246926,"twenty":27.570359,"median":35.90839,"eighty":45.208748,"marketCap":10049258243},{"date":"2023-06-09","current":20.951248,"twenty":27.505989,"median":35.626638,"eighty":45.208748,"marketCap":10398837716},{"date":"2023-06-16","current":21.549354,"twenty":27.38775,"median":35.168042,"eighty":45.208748,"marketCap":10695698762},{"date":"2023-06-23","current":21.05437,"twenty":27.302731,"median":34.967219,"eighty":45.22068,"marketCap":10450020655},{"date":"2023-06-30","current":21.57101,"twenty":27.216245,"median":34.765397,"eighty":45.232613,"marketCap":10706447180},{"date":"2023-07-07","current":21.383328,"twenty":27.178966,"median":34.533596,"eighty":45.232613,"marketCap":10613294231},{"date":"2023-07-14","current":21.568947,"twenty":27.142889,"median":34.210862,"eighty":45.232613,"marketCap":10705423521},{"date":"2023-07-21","current":21.035808,"twenty":27.004595,"median":33.939124,"eighty":45.165217,"marketCap":10440807726},{"date":"2023-07-28","current":21.501918,"twenty":26.874719,"median":33.714303,"eighty":45.092907,"marketCap":10672154610},{"date":"2023-08-04","current":20.78316,"twenty":26.73402,"median":33.532743,"eighty":44.947411,"marketCap":10315409526},{"date":"2023-08-11","current":23.050364,"twenty":26.596054,"median":33.34485,"eighty":44.848805,"marketCap":11157159996},{"date":"2023-08-18","current":21.171253,"twenty":26.426166,"median":33.220037,"eighty":44.772239,"marketCap":10247606123},{"date":"2023-08-25","current":21.038846,"twenty":26.315531,"median":33.087287,"eighty":44.736531,"marketCap":10183516927},{"date":"2023-09-01","current":21.907432,"twenty":26.157515,"median":32.81911,"eighty":44.601223,"marketCap":10603942054},{"date":"2023-09-08","current":21.650034,"twenty":26.042675,"median":32.657664,"eighty":44.514813,"marketCap":10479352657},{"date":"2023-09-15","current":22.007002,"twenty":25.855962,"median":32.571328,"eighty":44.410244,"marketCap":10652137130},{"date":"2023-09-22","current":20.989061,"twenty":25.680317,"median":32.237541,"eighty":44.266279,"marketCap":10159419389},{"date":"2023-09-29","current":20.688234,"twenty":25.591655,"median":32.055981,"eighty":44.1505,"marketCap":10013808735},{"date":"2023-10-06","current":20.247586,"twenty":25.472322,"median":31.91846,"eighty":44.065864,"marketCap":9800519890},{"date":"2023-10-13","current":20.023024,"twenty":25.362127,"median":31.46436,"eighty":43.983257,"marketCap":9691824613},{"date":"2023-10-20","current":19.850367,"twenty":25.256944,"median":31.376448,"eighty":43.817303,"marketCap":9608252301},{"date":"2023-10-27","current":18.54431,"twenty":25.245058,"median":31.264094,"eighty":43.648555,"marketCap":8976076469},{"date":"2023-11-03","current":18.506177,"twenty":25.120189,"median":31.076737,"eighty":43.39148,"marketCap":8957618781},{"date":"2023-11-10","current":18.303546,"twenty":25.039625,"median":31.01939,"eighty":43.179005,"marketCap":8693269373},{"date":"2023-11-17","current":20.47336,"twenty":24.794991,"median":30.960091,"eighty":42.931099,"marketCap":9723822166},{"date":"2023-11-24","current":21.267194,"twenty":24.632902,"median":30.893262,"eighty":42.832993,"marketCap":10100853675},{"date":"2023-12-01","current":21.285555,"twenty":24.512987,"median":30.831495,"eighty":42.722043,"marketCap":10109574132},{"date":"2023-12-08","current":21.900101,"twenty":24.443506,"median":30.761177,"eighty":42.674651,"marketCap":10401452947},{"date":"2023-12-15","current":24.761144,"twenty":24.235351,"median":30.687577,"eighty":42.504895,"marketCap":11760305285},{"date":"2023-12-22","current":25.458854,"twenty":24.235351,"median":30.569718,"eighty":42.504895,"marketCap":12091682638},{"date":"2023-12-29","current":25.789348,"twenty":24.210341,"median":30.549663,"eighty":42.509221,"marketCap":12248650859},{"date":"2024-01-05","current":24.122836,"twenty":24.185331,"median":30.507214,"eighty":42.513547,"marketCap":11457141173},{"date":"2024-01-12","current":23.054671,"twenty":24.062574,"median":30.339761,"eighty":42.513547,"marketCap":10949815781},{"date":"2024-01-19","current":22.260836,"twenty":23.822314,"median":30.295773,"eighty":42.530343,"marketCap":10572784272},{"date":"2024-01-26","current":23.008229,"twenty":23.586462,"median":30.222488,"eighty":42.513547,"marketCap":10927758156},{"date":"2024-02-02","current":23.711339,"twenty":23.569253,"median":30.129239,"eighty":42.257787,"marketCap":11261700350},{"date":"2024-02-09","current":23.628175,"twenty":23.556634,"median":30.086831,"eighty":42.068244,"marketCap":11222201811},{"date":"2024-02-16","current":26.549929,"twenty":23.556634,"median":30.066222,"eighty":42.036719,"marketCap":12601233558},{"date":"2024-02-23","current":26.712215,"twenty":23.556634,"median":30.047668,"eighty":42.036719,"marketCap":12678258213},{"date":"2024-03-01","current":27.500923,"twenty":23.557982,"median":30.026508,"eighty":42.02978,"marketCap":13052598036},{"date":"2024-03-08","current":29.240625,"twenty":23.557982,"median":29.977432,"eighty":42.02978,"marketCap":13878302337},{"date":"2024-03-15","current":28.183604,"twenty":23.557982,"median":29.942872,"eighty":42.02978,"marketCap":13376615085},{"date":"2024-03-22","current":29.582507,"twenty":23.557982,"median":29.851974,"eighty":42.02978,"marketCap":14040567611},{"date":"2024-03-28","current":29.143253,"twenty":23.557982,"median":29.783065,"eighty":42.02978,"marketCap":13832087544},{"date":"2024-04-05","current":27.119011,"twenty":23.556634,"median":29.703184,"eighty":42.036719,"marketCap":12871333348},{"date":"2024-04-12","current":26.660283,"twenty":23.556634,"median":29.592806,"eighty":42.036719,"marketCap":12653610323},{"date":"2024-04-19","current":24.61873,"twenty":23.556634,"median":29.571136,"eighty":42.036719,"marketCap":11684640163},{"date":"2024-04-26","current":24.64686,"twenty":23.557982,"median":29.568278,"eighty":42.02978,"marketCap":11697991103},{"date":"2024-05-03","current":24.871896,"twenty":23.557982,"median":29.52034,"eighty":42.02978,"marketCap":11804798625},{"date":"2024-05-10","current":26.924513,"twenty":23.557982,"median":29.495685,"eighty":42.02978,"marketCap":11815068579},{"date":"2024-05-17","current":26.048315,"twenty":23.557982,"median":29.495685,"eighty":42.02978,"marketCap":11577251653},{"date":"2024-05-24","current":25.213842,"twenty":23.557982,"median":29.495685,"eighty":42.02978,"marketCap":11206367506},{"date":"2024-05-31","current":24.306352,"twenty":23.557982,"median":29.495685,"eighty":42.02978,"marketCap":10803030997},{"date":"2024-06-07","current":25.685551,"twenty":23.557982,"median":29.495685,"eighty":42.02978,"marketCap":11416020072},{"date":"2024-06-14","current":24.621597,"twenty":23.556634,"median":29.498687,"eighty":42.036719,"marketCap":10943142786},{"date":"2024-06-21","current":24.295921,"twenty":23.554798,"median":29.495685,"eighty":42.042197,"marketCap":10798394945},{"date":"2024-06-28","current":24.031671,"twenty":23.549292,"median":29.498687,"eighty":42.058632,"marketCap":10680948299},{"date":"2024-07-05","current":23.34439,"twenty":23.54307,"median":29.465025,"eighty":42.058632,"marketCap":10375483995},{"date":"2024-07-12","current":24.440795,"twenty":23.487434,"median":29.444503,"eighty":42.058632,"marketCap":10862784554},{"date":"2024-07-15","current":25.056219,"twenty":23.487434,"median":29.444503,"eighty":42.058632,"marketCap":11136311612},{"date":"2024-08-02","current":28.144929,"twenty":23.388518,"median":29.436155,"eighty":42.123377,"marketCap":12509098071},{"date":"2024-08-09","current":23.61373,"twenty":23.378106,"median":29.39636,"eighty":42.123377,"marketCap":10425792501},{"date":"2024-08-16","current":23.632441,"twenty":23.359994,"median":29.388556,"eighty":42.123377,"marketCap":10434053417},{"date":"2024-08-23","current":23.543566,"twenty":23.359994,"median":29.388556,"eighty":42.123377,"marketCap":10394814065},{"date":"2024-08-30","current":23.305008,"twenty":23.353302,"median":29.388556,"eighty":42.123377,"marketCap":10289487384},{"date":"2024-09-06","current":22.357793,"twenty":23.32441,"median":29.384327,"eighty":42.123377,"marketCap":9871278503},{"date":"2024-09-13","current":22.723815,"twenty":23.2323,"median":29.355043,"eighty":42.123377,"marketCap":10032882676},{"date":"2024-09-20","current":24.513,"twenty":23.222682,"median":29.272841,"eighty":42.123377,"marketCap":10822832784},{"date":"2024-09-27","current":23.18456,"twenty":23.201419,"median":29.177469,"eighty":42.123377,"marketCap":10236307736},{"date":"2024-10-04","current":22.170688,"twenty":23.134212,"median":29.149308,"eighty":42.123377,"marketCap":9788669342},{"date":"2024-10-11","current":22.385858,"twenty":23.049905,"median":29.103556,"eighty":42.123377,"marketCap":9883669878},{"date":"2024-10-18","current":23.128429,"twenty":23.027566,"median":28.965102,"eighty":42.123377,"marketCap":10211524988},{"date":"2024-10-25","current":21.368479,"twenty":22.990023,"median":28.943424,"eighty":42.123377,"marketCap":9434482561},{"date":"2024-10-31","current":21.211779,"twenty":22.964878,"median":28.858713,"eighty":42.123377,"marketCap":9365297389},{"date":"2024-11-08","current":25.374902,"twenty":22.918988,"median":28.736458,"eighty":42.128701,"marketCap":10753426871},{"date":"2024-11-15","current":23.759181,"twenty":22.918988,"median":28.713491,"eighty":42.128701,"marketCap":10068713448},{"date":"2024-11-22","current":23.432176,"twenty":22.891683,"median":28.615557,"eighty":42.128701,"marketCap":9930134405},{"date":"2024-11-29","current":24.019821,"twenty":22.891683,"median":28.543867,"eighty":42.128701,"marketCap":10179167592},{"date":"2024-12-06","current":23.11241,"twenty":22.891683,"median":28.467301,"eighty":42.128701,"marketCap":9794623534},{"date":"2024-12-13","current":23.441829,"twenty":22.891683,"median":28.360227,"eighty":42.128701,"marketCap":9934225300},{"date":"2024-12-20","current":21.979355,"twenty":22.828292,"median":28.326416,"eighty":42.128701,"marketCap":9314454822},{"date":"2024-12-27","current":22.522353,"twenty":22.738216,"median":28.266911,"eighty":42.128701,"marketCap":9544567623},{"date":"2025-01-03","current":22.038481,"twenty":22.682211,"median":28.208114,"eighty":42.128701,"marketCap":9339511549},{"date":"2025-01-10","current":22.674392,"twenty":22.671591,"median":28.097903,"eighty":42.134026,"marketCap":9608999207},{"date":"2025-01-17","current":20.006462,"twenty":22.628656,"median":28.00534,"eighty":42.134026,"marketCap":8478378312},{"date":"2025-01-24","current":20.134368,"twenty":22.579584,"median":27.938758,"eighty":42.134026,"marketCap":8532582661},{"date":"2025-01-31","current":19.978708,"twenty":22.525173,"median":27.814535,"eighty":42.134026,"marketCap":8466616991},{"date":"2025-02-07","current":20.063175,"twenty":22.457433,"median":27.728386,"eighty":42.134026,"marketCap":8502412316},{"date":"2025-02-14","current":18.482447,"twenty":22.39192,"median":27.664206,"eighty":42.134026,"marketCap":7832528384},{"date":"2025-02-21","current":373.720927,"twenty":22.315695,"median":27.605873,"eighty":42.221721,"marketCap":8297725735},{"date":"2025-02-28","current":379.778776,"twenty":22.315695,"median":27.605873,"eighty":42.580733,"marketCap":8432228162},{"date":"2025-03-07","current":389.890547,"twenty":22.30517,"median":27.59024,"eighty":42.689144,"marketCap":8656739816},{"date":"2025-03-14","current":384.500674,"twenty":22.30517,"median":27.684039,"eighty":42.744591,"marketCap":8537068456},{"date":"2025-03-21","current":380.861357,"twenty":22.425618,"median":27.770246,"eighty":42.887645,"marketCap":8456264717},{"date":"2025-03-28","current":364.069828,"twenty":22.457192,"median":27.829549,"eighty":43.046551,"marketCap":8083442402},{"date":"2025-04-04","current":311.864751,"twenty":22.457192,"median":27.97626,"eighty":43.422763,"marketCap":6924333077},{"date":"2025-04-11","current":221.101446,"twenty":22.457433,"median":28.036465,"eighty":43.798993,"marketCap":4909115414},{"date":"2025-04-17","current":230.613565,"twenty":22.457433,"median":28.12608,"eighty":44.031266,"marketCap":5120312976},{"date":"2025-04-25","current":256.075072,"twenty":22.457192,"median":28.208114,"eighty":44.1505,"marketCap":5685634821},{"date":"2025-05-02","current":258.574768,"twenty":22.457192,"median":28.257174,"eighty":44.330713,"marketCap":5741135575},{"date":"2025-05-09","current":-353.207359,"twenty":22.425618,"median":28.266911,"eighty":44.43056,"marketCap":6942997048},{"date":"2025-05-16","current":-347.035725,"twenty":22.30517,"median":28.149428,"eighty":44.43056,"marketCap":6821681239},{"date":"2025-05-23","current":-338.815208,"twenty":22.274987,"median":28.054858,"eighty":44.43056,"marketCap":6660090547},{"date":"2025-05-30","current":-344.062346,"twenty":22.210378,"median":27.97626,"eighty":44.43056,"marketCap":6763233542},{"date":"2025-06-06","current":-352.807577,"twenty":22.101227,"median":27.829549,"eighty":44.43056,"marketCap":6935138534},{"date":"2025-06-13","current":-379.518009,"twenty":22.038481,"median":27.71316,"eighty":44.43056,"marketCap":7460185495},{"date":"2025-06-20","current":-363.027003,"twenty":21.980898,"median":27.632939,"eighty":44.432965,"marketCap":7136021796},{"date":"2025-06-27","current":-378.768417,"twenty":21.905966,"median":27.544543,"eighty":44.432965,"marketCap":7445450782},{"date":"2025-07-03","current":-392.585881,"twenty":21.843256,"median":27.35517,"eighty":44.432965,"marketCap":7717060669},{"date":"2025-07-11","current":-408.926969,"twenty":21.779083,"median":27.197606,"eighty":44.432965,"marketCap":8038277425},{"date":"2025-07-18","current":-391.536454,"twenty":21.672859,"median":27.117722,"eighty":44.432965,"marketCap":7696432070},{"date":"2025-07-25","current":-442.508653,"twenty":21.63318,"median":27.002298,"eighty":44.432965,"marketCap":8698392595},{"date":"2025-08-01","current":-423.868819,"twenty":21.58689,"median":26.866903,"eighty":44.432965,"marketCap":8331989383},{"date":"2025-08-08","current":-109.948833,"twenty":21.557199,"median":26.733131,"eighty":44.432965,"marketCap":7371299580},{"date":"2025-08-15","current":-114.367927,"twenty":21.516039,"median":26.61679,"eighty":44.432965,"marketCap":7667568932},{"date":"2025-08-22","current":-113.443,"twenty":21.486853,"median":26.510016,"eighty":44.432965,"marketCap":7605559068},{"date":"2025-08-29","current":-119.814718,"twenty":21.402537,"median":26.411134,"eighty":44.432965,"marketCap":8032738133},{"date":"2025-09-05","current":-119.146715,"twenty":21.37942,"median":26.315531,"eighty":44.43537,"marketCap":7987953231},{"date":"2025-09-12","current":-117.260158,"twenty":21.338986,"median":26.133133,"eighty":44.432965,"marketCap":7861472793},{"date":"2025-09-19","current":-115.241469,"twenty":21.287283,"median":26.060047,"eighty":44.432965,"marketCap":7726133804},{"date":"2025-09-26","current":-106.858403,"twenty":21.273794,"median":25.958737,"eighty":44.432965,"marketCap":7164107891},{"date":"2025-10-03","current":-128.726314,"twenty":21.241751,"median":25.863499,"eighty":44.432965,"marketCap":8630198254},{"date":"2025-10-10","current":-126.362612,"twenty":21.211088,"median":25.753854,"eighty":44.432965,"marketCap":8471728600},{"date":"2025-10-17","current":-128.425346,"twenty":21.170769,"median":25.684971,"eighty":44.25356,"marketCap":8610020441},{"date":"2025-10-24","current":-140.185129,"twenty":21.155787,"median":25.612602,"eighty":44.25356,"marketCap":9398431572},{"date":"2025-10-31","current":-131.479072,"twenty":21.068068,"median":25.524494,"eighty":44.25356,"marketCap":8814751421},{"date":"2025-11-07","current":-102.213711,"twenty":21.034347,"median":25.460925,"eighty":44.25356,"marketCap":8409939684},{"date":"2025-11-14","current":-101.214782,"twenty":20.974347,"median":25.427998,"eighty":44.25356,"marketCap":8327749847},{"date":"2025-11-21","current":-96.949896,"twenty":20.878264,"median":25.352123,"eighty":44.25356,"marketCap":7976843539},{"date":"2025-11-28","current":-106.556358,"twenty":20.786459,"median":25.294334,"eighty":44.25356,"marketCap":8767244003},{"date":"2025-12-05","current":-110.085506,"twenty":20.761869,"median":25.238501,"eighty":44.25356,"marketCap":9057615282},{"date":"2025-12-12","current":-116.300397,"twenty":20.715668,"median":25.1676,"eighty":44.25356,"marketCap":9568964026},{"date":"2025-12-19","current":-115.953463,"twenty":20.610715,"median":25.113279,"eighty":44.25356,"marketCap":9540419053},{"date":"2025-12-26","current":-121.52234,"twenty":20.557942,"median":25.063738,"eighty":44.25356,"marketCap":9998615088},{"date":"2026-01-02","current":-119.321108,"twenty":20.491885,"median":25.002257,"eighty":44.25356,"marketCap":9817502155},{"date":"2026-01-09","current":-128.909625,"twenty":20.448202,"median":24.893747,"eighty":44.20765,"marketCap":10606426155},{"date":"2026-01-16","current":-133.670985,"twenty":20.330014,"median":24.833416,"eighty":44.1505,"marketCap":10998181304},{"date":"2026-01-23","current":-134.005955,"twenty":20.298109,"median":24.777229,"eighty":43.853216,"marketCap":11025741968},{"date":"2026-01-30","current":-126.61867,"twenty":20.244304,"median":24.640819,"eighty":43.786866,"marketCap":10417930901},{"date":"2026-02-06","current":-109.882132,"twenty":20.193072,"median":24.591663,"eighty":43.217308,"marketCap":9040882022},{"date":"2026-02-13","current":-94.952039,"twenty":20.07379,"median":24.511667,"eighty":42.849981,"marketCap":7812463866},{"date":"2026-02-20","current":-56.01556,"twenty":20.017378,"median":24.49764,"eighty":42.835932,"marketCap":8085173872},{"date":"2026-02-27","current":-59.842244,"twenty":19.971304,"median":24.411734,"eighty":42.835932,"marketCap":8637509788},{"date":"2026-03-06","current":-61.840851,"twenty":19.87854,"median":24.32154,"eighty":42.835932,"marketCap":8925984696},{"date":"2026-03-13","current":-52.066095,"twenty":19.743612,"median":24.287097,"eighty":42.835932,"marketCap":7515115948},{"date":"2026-03-20","current":-52.199108,"twenty":19.680798,"median":24.187025,"eighty":42.835932,"marketCap":7534314790},{"date":"2026-03-27","current":-56.319102,"twenty":19.504007,"median":24.13868,"eighty":42.835932,"marketCap":8128986614},{"date":"2026-04-02","current":-59.651251,"twenty":19.268028,"median":24.082006,"eighty":42.835932,"marketCap":8609942220},{"date":"2026-04-10","current":-59.872939,"twenty":18.935158,"median":24.025746,"eighty":42.835932,"marketCap":8641940290},{"date":"2026-04-17","current":-60.486957,"twenty":18.536683,"median":23.958332,"eighty":42.715799,"marketCap":8730566402},{"date":"2026-04-24","current":-57.341936,"twenty":18.29916,"median":23.859941,"eighty":42.496242,"marketCap":8276620370},{"date":"2026-05-01","current":-57.078712,"twenty":-51.87783,"median":23.809151,"eighty":41.968433,"marketCap":8238627061},{"date":"2026-05-08","current":-47.392259,"twenty":-52.543578,"median":23.77561,"eighty":40.543299,"marketCap":8750980560},{"date":"2026-05-15","current":-41.507984,"twenty":-52.543578,"median":23.664176,"eighty":39.11878,"marketCap":7664449197},{"date":"2026-05-22","current":-41.44016,"twenty":-52.543578,"median":23.615584,"eighty":37.979151,"marketCap":7651925587},{"date":"2026-05-29","current":-47.304285,"twenty":-52.662948,"median":23.569253,"eighty":37.619991,"marketCap":8734736158},{"date":"2026-06-05","current":-48.46511,"twenty":-52.543578,"median":23.5457,"eighty":37.43293,"marketCap":8949082556},{"date":"2026-06-12","current":-49.057261,"twenty":-52.543578,"median":23.498853,"eighty":37.123983,"marketCap":9058423303},{"date":"2026-06-18","current":-47.565144,"twenty":-52.543578,"median":23.451184,"eighty":36.986616,"marketCap":8782903888},{"date":"2026-06-26","current":-55.487451,"twenty":-53.246159,"median":23.360453,"eighty":36.547383,"marketCap":10245757848},{"date":"2026-07-02","current":-59.760332,"twenty":-54.287072,"median":23.34439,"eighty":36.027412,"marketCap":11034745265},{"date":"2026-07-10","current":-60.936809,"twenty":-56.011457,"median":23.305008,"eighty":34.786875,"marketCap":11251981728},{"date":"2026-07-17","current":-59.778592,"twenty":-56.650537,"median":23.211309,"eighty":33.27429,"marketCap":11038117006},{"date":"2026-07-24","current":-59.812504,"twenty":-57.108995,"median":23.140407,"eighty":31.657171,"marketCap":11044378811},{"date":"2026-07-31","current":-61.202886,"twenty":-57.360559,"median":23.115402,"eighty":30.233792,"marketCap":11301112812},{"date":"2026-08-07","current":-53.154635,"twenty":-57.738591,"median":23.045939,"eighty":29.797035,"marketCap":12675147904},{"date":"2026-08-14","current":-56.309759,"twenty":-57.738591,"median":23.012549,"eighty":29.530231,"marketCap":13427512527},{"date":"2026-08-21","current":-58.347777,"twenty":-58.052953,"median":22.973199,"eighty":29.423369,"marketCap":13913494244},{"date":"2026-08-28","current":-59.34076,"twenty":-58.530539,"median":22.938645,"eighty":29.277136,"marketCap":14150279049},{"date":"2026-09-04","current":-58.728154,"twenty":-58.65089,"median":22.89974,"eighty":29.136438,"marketCap":14004198101},{"date":"2026-09-09","current":-56.207658,"twenty":-58.65089,"median":22.89213,"eighty":29.109011,"marketCap":13403165702}],"updateTime":1789077042046},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRL\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2642238015","title":"Leerink sees favorable readthrough to Crinetics after Camurus’ Oclaiz CRL","url":"https://stock-news.laohu8.com/highlight/detail?id=2642238015","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642238015?lang=en_us&edition=fundamental","pubTime":"2026-06-11 23:05","pubTimestamp":1781190353,"startTime":"0","endTime":"0","summary":"Leerink analyst Joseph Schwartz notes that Camurus received a complete response letter for Oclaiz in acromegaly. The firm sees positive readthrough...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/leerink-sees-favorable-readthrough-to-crinetics-after-camurus-oclaiz-crl-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/leerink-sees-favorable-readthrough-to-crinetics-after-camurus-oclaiz-crl-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4121","BK4530","IE00BFMHRM44.USD","CRL","BK4588","LU0757428866.USD","LU1815336091.USD","LU0128526141.USD","LU0029874061.USD","LU0390134368.USD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642446058","title":"Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria","url":"https://stock-news.laohu8.com/highlight/detail?id=2642446058","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642446058?lang=en_us&edition=fundamental","pubTime":"2026-06-09 20:30","pubTimestamp":1781008200,"startTime":"0","endTime":"0","summary":"Aligned with the FDA that the Phase 3 APOLLO study, if successful, can serve as the basis for CRL response and could potentially support a traditional approvalOn track for expected CRL response submis","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/09/3308825/0/en/Disc-Medicine-Provides-Update-from-FDA-Type-A-Meeting-for-Bitopertin-in-Erythropoietic-Protoporphyria.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4582","BK4588","EPP","LU0128526141.USD","LU0757428866.USD","BK4530","LU1815336091.USD","XLP","LABU","BK4585","CRL","IRON","LU0053671581.USD","LU0029874061.USD","IE00BFMHRM44.USD","BK4121","LU0390134368.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2642943408","title":"Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2642943408","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2642943408?lang=en_us&edition=fundamental","pubTime":"2026-06-09 05:17","pubTimestamp":1780953420,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Charles River Laboratories International Inc.  rose 2.81% to $186.44 Monday, on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index  rising 0.30% to 7,405.73 and the Dow Jones Industrial Average  falling 0.16% to 50,786.01.Charles River Laboratories International Inc. closed 18.54% below its 52-week high of $228.88, which the company reached on January 13th.The stock outperformed some of its competitors Monday, as Labcorp Holdings Inc.  fell 1.18% to $262.01, Alnylam Pharmaceuticals Inc.  fell 3.59% to $292.16, and Bio-Techne Corp.  rose 1.27% to $52.65.Trading volume  remained 124,160 below its 50-day average volume of 883,054.Data source: Dow Jones Market Data, FactSet. Data compiled June 8, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswi","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641100870","title":"Analysts Offer Insights on Healthcare Companies: Charles River Labs (CRL), Incyte (INCY) and Pfizer (PFE)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641100870","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641100870?lang=en_us&edition=fundamental","pubTime":"2026-06-08 16:50","pubTimestamp":1780908606,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Charles River Labs (CRL), Incyte (INCY) and Pfizer...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-incyte-incy-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-charles-river-labs-crl-incyte-incy-and-pfizer-pfe-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LU0321505439.SGD","IE00B3T34201.USD","LU0321505868.SGD","IE00B19Z3581.USD","LU0234572021.USD","SG9999011175.SGD","BK4588","SG9999001176.SGD","BK4534","LU1894683264.USD","LU0170899867.USD","LU0390134368.USD","SG9999003800.SGD","LU0868494617.USD","BK4139","SGXZ57979304.SGD","BK4599","BK4585","LU1066053197.SGD","LU0306806265.USD","SG9999001176.USD","IE0002270589.USD","LU0456855351.SGD","CRL","BK4121","IE00BLSP4452.SGD","LU1057294990.SGD","IE00BFMHRM44.USD","LU0289739699.SGD","LU2596442595.SGD","BK4568","LU0757428866.USD","PFE","LU0306807586.USD","SG9999002232.USD","IE00BBT3K403.USD","LU0225771236.USD","IE00BLSP4239.USD","LU0985481810.HKD","LU0029874061.USD","LU1023059063.AUD","LU0225284248.USD","LU0122379950.USD","BK4533","LU0058720904.USD","IE00B19Z3B42.SGD","LU1066051498.USD","LU1894683348.USD","SG9999013999.USD","BK4530","BK4592","LU0128526141.USD","BK4550","IE000M9KFDE8.USD","SG9999002224.SGD","BK4532","LU1883839398.USD","BK4581","INCY","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641128848","title":"Charles River Laboratories International Inc. Stock Underperforms Friday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2641128848","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641128848?lang=en_us&edition=fundamental","pubTime":"2026-06-06 05:17","pubTimestamp":1780694220,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Charles River Laboratories International Inc.  shed 2.40% to $181.34 Friday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index  falling 2.64% to 7,383.74 and Dow Jones Industrial Average  falling 1.35% to 50,866.78.The stock's fall snapped a two-day winning streak.Charles River Laboratories International Inc. closed 20.77% below its 52-week high of $228.88, which the company achieved on January 13th.The stock underperformed when compared to some of its competitors Friday, as Labcorp Holdings Inc.  rose 1.60% to $265.15, Alnylam Pharmaceuticals Inc.  fell 0.19% to $303.05, and Bio-Techne Corp.  fell 2.24% to $51.99.Trading volume  remained 374,064 below its 50-day average volume of 893,340.Data source: Dow Jones Market Data, FactSet. Data compiled June 5, 2026.This content was created by MarketWatch, which is operated by Dow Jones ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641005144","title":"Analysts Are Bullish on Top Healthcare Stocks: Charles River Labs (CRL), TransMedics Group (TMDX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641005144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641005144?lang=en_us&edition=fundamental","pubTime":"2026-06-06 02:12","pubTimestamp":1780683155,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Charles River Labs (CRL) and TransMedics Group (TMDX...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-charles-river-labs-crl-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-are-bullish-on-top-healthcare-stocks-charles-river-labs-crl-transmedics-group-tmdx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1815336091.USD","LU2065731478.USD","LU2324357040.USD","IE00BFMHRM44.USD","BK4530","BK4082","LU0128526141.USD","BK4121","BK4585","BK4588","LU0029874061.USD","TMDX","CRL","LU0390134368.USD","LU0757428866.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641448311","title":"RBC Capital Keeps Their Buy Rating on Charles River Labs (CRL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2641448311","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641448311?lang=en_us&edition=fundamental","pubTime":"2026-06-06 00:57","pubTimestamp":1780678665,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Ryan Halsted reiterated a Buy rating on Charles River Labs yesterday and set a price target of $215.00. Halsted covers the Heal...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-charles-river-labs-crl-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2641514677","title":"Charles River Laboratories Has Potential to Outperform in 2H 2026, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2641514677","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2641514677?lang=en_us&edition=fundamental","pubTime":"2026-06-05 22:53","pubTimestamp":1780671236,"startTime":"0","endTime":"0","summary":"Charles River Laboratories  has the potential to outperform expectations in the second half of 2026, RBC Capital Markets analysts said in a Thursday note.Analysts said that the company's \"Pathways to Purpose\" strategy is positioning it to capitalize on improving biotech funding and pharma investment in research and development.RBC said that the company sees various opportunities, including in China, New Alternative Methods, and organic market share gains from a recent competitor's bankruptcy.\"We expect strong biopharma funding to continue in 2026 which combined with healthy cash runways should manifest in accelerated preclinical R&D spending growth in 2026 and into 2027,\" analysts said.RBC has an outperform rating and a $215 price target on the stock.Price: 184.94, Change: -0.85, Percent Change: -0.46","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640157064","title":"Analysts Have Conflicting Sentiments on These Healthcare Companies: Amneal Pharmaceuticals (AMRX), Charles River Labs (CRL) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2640157064","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640157064?lang=en_us&edition=fundamental","pubTime":"2026-06-04 20:40","pubTimestamp":1780576825,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Amneal Pharmaceuticals (AMRX), Charles River Labs ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-amneal-pharmaceuticals-amrx-charles-river-labs-crl-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-have-conflicting-sentiments-on-these-healthcare-companies-amneal-pharmaceuticals-amrx-charles-river-labs-crl-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","BK4581","BK4121","AXSM","LU0128526141.USD","LU0390134368.USD","CRL","LU1815336091.USD","HCSG","LU0757428866.USD","BK4007","AMRX","BK4585","XLV","BK4588","LABU","BK4137","IE00BFMHRM44.USD","XBI","LU0029874061.USD","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640317621","title":"Pharming announces U.S. FDA acceptance of sNDA resubmission for Joenja® (leniolisib) to treat children aged 4 to 11 years with APDS","url":"https://stock-news.laohu8.com/highlight/detail?id=2640317621","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640317621?lang=en_us&edition=fundamental","pubTime":"2026-06-04 13:00","pubTimestamp":1780549200,"startTime":"0","endTime":"0","summary":"If approved, Joenjawill be thefirst approvedtreatmentin the U.S. for childrenwithactivatedphosphoinositide 3-kinase delta (PI3Kδ)syndrome (APDS), a rare primary immunodeficiency Supplemental New Drug ","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/04/3306506/0/en/Pharming-announces-U-S-FDA-acceptance-of-sNDA-resubmission-for-Joenja-leniolisib-to-treat-children-aged-4-to-11-years-with-APDS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0757428866.USD","IE00BFMHRM44.USD","LU0128526141.USD","BK4121","BK4530","LU0390134368.USD","BK4588","LU0029874061.USD","LU1815336091.USD","LABU","BK4585","CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640182364","title":"Charles River Laboratories International Inc. Stock Outperforms Competitors On Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2640182364","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640182364?lang=en_us&edition=fundamental","pubTime":"2026-06-04 05:18","pubTimestamp":1780521480,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Charles River Laboratories International Inc.  rallied 2.91% to $179.87 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.74% to 7,553.68 and Dow Jones Industrial Average  falling 1.21% to 50,687.07.Charles River Laboratories International Inc. closed 21.41% short of its 52-week high of $228.88, which the company achieved on January 13th.The stock outperformed some of its competitors Wednesday, as Labcorp Holdings Inc.  rose 0.47% to $258.92, Alnylam Pharmaceuticals Inc.  rose 2.26% to $292.58, and Bio-Techne Corp.  rose 2.17% to $50.85.Trading volume  remained 363,749 below its 50-day average volume of 899,538.Data source: Dow Jones Market Data, FactSet. Data compiled June 3, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jon","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640261921","title":"Max Smock Reiterates Buy on Charles River Laboratories, Citing Achievable 2026 Targets and Margin Expansion Upside","url":"https://stock-news.laohu8.com/highlight/detail?id=2640261921","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640261921?lang=en_us&edition=fundamental","pubTime":"2026-06-03 07:35","pubTimestamp":1780443323,"startTime":"0","endTime":"0","summary":"William Blair analyst Max Smock has maintained their bullish stance on CRL stock, giving a Buy rating on May 29. Max Smock has given his Buy rating...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/ratings/max-smock-reiterates-buy-on-charles-river-laboratories-citing-achievable-2026-targets-and-margin-expansion-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/ratings/max-smock-reiterates-buy-on-charles-river-laboratories-citing-achievable-2026-targets-and-margin-expansion-upside-ratings-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128526141.USD","BK4588","LU0390134368.USD","LU1815336091.USD","BK4121","LU0029874061.USD","IE00BFMHRM44.USD","BK4530","LU0757428866.USD","CRL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640926469","title":"Charles River Laboratories International Inc. Stock Underperforms Tuesday When Compared To Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2640926469","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640926469?lang=en_us&edition=fundamental","pubTime":"2026-06-03 05:17","pubTimestamp":1780435020,"startTime":"0","endTime":"0","summary":"This article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Charles River Laboratories International Inc.  shed 4.00% to $174.79 Tuesday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index  rising 0.13% to 7,609.78 and the Dow Jones Industrial Average  rising 0.45% to 51,307.79.Charles River Laboratories International Inc. closed 23.63% below its 52-week high of $228.88, which the company achieved on January 13th.The stock underperformed when compared to some of its competitors Tuesday, as Labcorp Holdings Inc.  rose 0.32% to $257.70, Alnylam Pharmaceuticals Inc.  fell 3.22% to $286.12, and Bio-Techne Corp.  fell 2.01% to $49.77.Trading volume  remained 148,961 below its 50-day average volume of 900,665.Data source: Dow Jones Market Data, FactSet. Data compiled June 2, 2026.This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independen","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640902028","title":"URA announces nine new sites under Confirmed List in 2H2026 GLS programme, including white site at Jurong Lake District","url":"https://stock-news.laohu8.com/highlight/detail?id=2640902028","media":"Jovi Ho","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640902028?lang=en_us&edition=fundamental","pubTime":"2026-06-03 01:27","pubTimestamp":1780421221,"startTime":"0","endTime":"0","summary":"With a total potential yield of about 186,000 sqm, including up to 1,200 private residential units, the white site at Town Hall Link will be launched for tender in July.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/cityandcountry/property/ura-announces-nine-new-sites-under-confirmed-list-2h2026-gls-programme?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/cityandcountry/property/ura-announces-nine-new-sites-under-confirmed-list-2h2026-gls-programme?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["LU0757428866.USD","BK4530","BK4588","ARKX","IE00BFMHRM44.USD","LU0029874061.USD","BK4544","UFO","BK4564","BK4121","LU1815336091.USD","GLS","BK4606","BK4139","CRL","LU0128526141.USD","BK4585","LU0390134368.USD","URA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640436869","title":"Charles River Laboratories posts investor presentation on growth strategy, demand trends and 2026 outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2640436869","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640436869?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:46","pubTimestamp":1780404381,"startTime":"0","endTime":"0","summary":"Charles River outlined 2026 guidance reflecting completed May divestitures, projecting organic revenue down 1.5% to 0.5%.Non-GAAP operating margin forecast to rise about 120-150 bps versus 19.8% in 2025.EPS outlook set at GAAP USD 5.35-5.85; non-GAAP USD 10.8-11.3; free cash flow targeted at USD 375-400 million.1Q26 revenue rose 1.2% to USD 995.8 million; non-GAAP operating margin fell to 16.3% from 19.1%.Cost program targets over USD 100 million incremental savings in 2026; over USD 300 million annualized savings over time.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief on June 02, 2026, and is solely responsible for the infor","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL4XK8s6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","BK4588","LU0390134368.USD","LU1815336091.USD","BK4121","LU0029874061.USD","IE00BFMHRM44.USD","BK4530","LU0757428866.USD","CRL","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1110826926","title":"FDA Declines Approval for Cingulate's ADHD Treatment Candidate","url":"https://stock-news.laohu8.com/highlight/detail?id=1110826926","media":"Deep News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1110826926?lang=en_us&edition=fundamental","pubTime":"2026-06-02 20:30","pubTimestamp":1780403428,"startTime":"0","endTime":"0","summary":"The U.S. pharmaceutical company Cingulate announced on the 2nd that the U.S. Food and Drug Administration (FDA) has declined to approve its investigational new drug CTx-1301 for the treatment of...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","LU0390134368.USD","ADHD","BK4121","LU1815336091.USD","IE00BFMHRM44.USD","BK4588","CRL","LU0128526141.USD","LU0757428866.USD","LU0029874061.USD","BK4530"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640200961","title":"Nyse Order Imbalance  67834.0 Shares on Buy Side","url":"https://stock-news.laohu8.com/highlight/detail?id=2640200961","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640200961?lang=en_us&edition=fundamental","pubTime":"2026-06-02 03:50","pubTimestamp":1780343405,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nAQN2M1IH3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1815336091.USD","BK4530","BK4121","LU0757428866.USD","LU0128526141.USD","CRL","IE00BFMHRM44.USD","LU0390134368.USD","BK4585","BK4588","LU0029874061.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640951219","title":"Disc Medicine Launches Expanded Access Program for Bitopertin for EPP Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2640951219","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640951219?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:30","pubTimestamp":1780317000,"startTime":"0","endTime":"0","summary":"The expanded access program (EAP) is available to eligible patients with erythropoietic protoporphyria (EPP) and provides access to bitopertin prior to regulatory decisionBitopertin, an oral glycine t","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/06/01/3304352/0/en/Disc-Medicine-Launches-Expanded-Access-Program-for-Bitopertin-for-EPP-Patients.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL","BK4139","LU0029874061.USD","IRON","LU0128526141.USD","BK4588","LU0390134368.USD","LU0757428866.USD","XLP","BK4530","BK4585","IE00BFMHRM44.USD","BK4582","LU0053671581.USD","EPP","LU1815336091.USD","BK4121"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640464959","title":"Charles River Labs to present at William Blair Growth Stock Conference","url":"https://stock-news.laohu8.com/highlight/detail?id=2640464959","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640464959?lang=en_us&edition=fundamental","pubTime":"2026-06-01 20:00","pubTimestamp":1780315244,"startTime":"0","endTime":"0","summary":"Charles River Laboratories will present at the William Blair 46th Annual Growth Stock Conference on June 2 at 10:00 a.m. CT.It will also present at the Jefferies Global Healthcare Conference on June 3 at 9:55 a.m. ET.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Charles River Laboratories International Inc. published the original content used to generate this news brief via Business Wire  on June 01, 2026, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDL8ybjLp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0128526141.USD","LU0390134368.USD","BK4585","BK4530","BK4121","CRL","LU0757428866.USD","LU0029874061.USD","BK4588","IE00BFMHRM44.USD","LU1815336091.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639361982","title":"Charles River Laboratories International Inc. Stock Advances 10.2%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2639361982","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639361982?lang=en_us&edition=fundamental","pubTime":"2026-05-29 04:33","pubTimestamp":1780000380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Charles River Laboratories International Inc. climbed 10.2% to $181.34 on what proved to be an all-around mixed trading session for the stock market, with the S&P 500 Index rising 0.6% to 7,563.63 and the Dow Jones Industrial Average remaining mostly unchanged at 50,668.97.This was the stock's second consecutive day of gains.Charles River Laboratories International Inc. closed 20.8% below its 52-week high of $228.88, which the company achieved on January 13th.The stock outperformed some of its peers, as Labcorp Holdings Inc. rose 1.7% to $262.75, Alnylam Pharmaceuticals Inc. rose 3.2% to $305.06, and Bio-Techne Corp. rose 5.72% to $50.84.Trading volume totaled 1.3 million, compared to the 50-day average of 880,616.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":200,"code":"91000000","status":"200"}]}}